1.
Pathophysiology and treatment of type 2 diabetes: perspectives on the past, present, and future
by Kahn, Steven E, Prof
The Lancet (British edition), 2014, Vol.383 (9922), p.1068-1083

2.
The many faces of diabetes: a disease with increasing heterogeneity
by Tuomi, Tiinamaija, MD
The Lancet (British edition), 2014, Vol.383 (9922), p.1084-1094

3.
Type 1 diabetes
by Atkinson, Mark A, Prof
The Lancet (British edition), 2014, Vol.383 (9911), p.69-82

4.

5.
Prevalence of diabetes mellitus and impaired glucose regulation in Spain: the Di@bet.es Study
by Soriguer, F
Diabetologia, 2011-10-11, Vol.55 (1), p.88-93

6.
Periodontitis and diabetes: a two-way relationship
by Preshaw, P. M
Diabetologia, 2011-11-06, Vol.55 (1), p.21-31

7.
Type 2 diabetes mellitus after gestational diabetes: a systematic review and meta-analysis
by Bellamy, Leanne, MBBS
The Lancet (British edition), 2009, Vol.373 (9677), p.1773-1779

8.
Molecular mechanisms of diabetic cardiomyopathy
by Bugger, Heiko
Diabetologia, 2014-01-30, Vol.57 (4), p.660-671

9.
Twelve-year trends in the prevalence and risk factors of diabetes and prediabetes in Turkish adults
by Satman, Ilhan
European journal of epidemiology, 2013-01-01, Vol.28 (2), p.169-180

10.
Type 2 diabetes across generations: from pathophysiology to prevention and management
by Nolan, Christopher J, Assoc Prof
The Lancet (British edition), 2011, Vol.378 (9786), p.169-181

11.
Diabetes and cognitive dysfunction
by McCrimmon, Rory J, Dr
The Lancet (British edition), 2012, Vol.379 (9833), p.2291-2299

12.
National, regional, and global trends in fasting plasma glucose and diabetes prevalence since 1980: systematic analysis of health examination surveys and epidemiological studies wi...
by Danaei, Goodarz, MD
The Lancet (British edition), 2011, Vol.378 (9785), p.31-40

13.
Reversal of type 2 diabetes: normalisation of beta cell function in association with decreased pancreas and liver triacylglycerol
by Lim, E. L
Diabetologia, 2011-06-09, Vol.54 (10), p.2506-2514

14.
Impact of age, age at diagnosis and duration of diabetes on the risk of macrovascular and microvascular complications and death in type 2 diabetes
by Zoungas, Sophia
Diabetologia, 2014-09-17, Vol.57 (12), p.2465-2474

15.
Effectiveness of quality improvement strategies on the management of diabetes: a systematic review and meta-analysis
by Tricco, Andrea C, Dr
The Lancet (British edition), 2012, Vol.379 (9833), p.2252-2261

16.
Diabetes in sub-Saharan Africa
by Mbanya, Jean Claude N, Prof
The Lancet (British edition), 2010, Vol.375 (9733), p.2254-2266

17.
Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies
by Sarwar, N
The Lancet (British edition), 2010, Vol.375 (9733), p.2215-2222

18.
Efficacy and safety of canagliflozin compared with placebo and sitagliptin in patients with type 2 diabetes on background metformin monotherapy: a randomised trial
by Lavalle-González, F. J
Diabetologia, 2013-09-13, Vol.56 (12), p.2582-2592

19.
The mechanisms of alloxan- and streptozotocin-induced diabetes
by Lenzen, S
Diabetologia, 2007-12-18, Vol.51 (2), p.216-226

20.
